| 摘要 |
The invention is directed to the use of IL-12R 1/IL-23R, CCR6, BATF, AHR, STAT3, IRF4 crucial actors in Thl7 cells differentiation as new markers for acne, and their use to diagnose acne, to screen inhibitors of Th17 differentiation, notably in inhibiting IL-12R 1/IL-23R, CCR6, BATF, AHR, STAT3,IRF4 and the use of these screened inhibitors in acne treatment. |
